MDS Pharma Services, a leading provider of innovative drug discovery and development solutions, has launched a new brand promise - "to deliver high-quality services on-time" - as part of their strategic plan to become the industry leader in quality, compliance and client service. This new brand campaign has been developed in response to market research with hundreds of clients around the world. The research revealed that high quality, on-time delivery is a top priority with clients striving to move new drugs to market quickly and efficiently.
"We recognize the importance of high quality, on-time delivery for clients in every phase of the drug discovery and development process," said MDS Pharma Services President David Spaight. "At MDS Pharma Services, our employees are committed to this brand promise as part of our global strategy to support our clients' success."
MDS Pharma Services unveiled its new brand campaign at the annual meeting of the American Association of Pharmaceutical Scientists (AAPS) which opened yesterday in San Diego. This new branding has been captured visually with a high speed train moving to its destination on-time. This brand image will be promoted online, in print and at more than two dozen industry events in the coming year.
The brand promise is also reflected in the contract research organization's operational priorities. These priorities emphasize providing high quality, on-time services by investing in new customer facing information technology systems and by using LeanSigma and other process improvement initiatives to expedite the drug discovery and development process. MDS Pharma Services has almost 100 LeanSigma projects completed or underway to reduce the time for clients to reach milestones such as the start-up of studies, biomarker development methods and report delivery.
About MDS Pharma Services
MDS Pharma Services is committed to its brand promise of delivering high-quality services on-time to clients. The business offers a full spectrum of resources to meet the drug discovery and development needs of the pharmaceutical and biotechnology industries. With numerous facilities strategically located around the world, we apply advanced scientific and technological expertise throughout the drug discovery and development process - from lead optimization, pre-IND research, early clinical research (bioequivalence, phases I-IIa) and bioanalysis through to global clinical development (phases IIb-IV), central lab and centralized cardiac services. For more information, visit our website at www.mdsps.com.
MDS Pharma Services is a business unit of MDS Inc. , a global life sciences company that provides market-leading products and services that our customers need for the development of drugs and diagnosis and treatment of disease. We are a leading global provider of pharmaceutical contract research, medical isotopes for molecular imaging, radiotherapeutics, and analytical instruments. MDS has more than 6,200 highly skilled people in 28 countries. Find out more at www.mdsinc.com or by calling 1-888-MDS-7222, 24 hours a day.
No comments:
Post a Comment